Dopamine-Blocking Antipsychotics—Time for a New Conversation With Patients?

This Viewpoint discusses what the role of dopamine blockers and non–dopamine-blocking antipsychotics may have in psychiatric practice.

Authors

Institutions

Publication Details

Journal
JAMA Psychiatry
Published
2025-11-26
DOI
https://doi.org/10.1001/jamapsychiatry.2025.3572
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dopamine-Blocking Antipsychotics—Time for a New Conversation With Patients?

Sean B. Ostlund, Stephen R. Marder
JAMA Psychiatry
Schizophrenia research and treatment
article

Dopamine-Blocking Antipsychotics—Time for a New Conversation With Patients?

Sean B. Ostlund, Stephen R. Marder
article en

Abstract

This Viewpoint discusses what the role of dopamine blockers and non–dopamine-blocking antipsychotics may have in psychiatric practice.

JAMA PsychiatryVol. 83(2)
Neurosciences Institute (US), University of California, Irvine (US), VA Desert Pacific Healthcare Network (US)
Openalex Percentile: Top 57%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dopamine-Blocking Antipsychotics—Time for a New Conversation With Patients? — Sean B. Ostlund, Stephen R. Marder · JAMA Psychiatry (2025) | TGRS Research Map | TGRS